Gradientechs vd Sara Thorslund var en av deltagarna på Redeyes Medtech & Diagnostic Day 2021. Hon berättade där bland annat om bolagets planer för markandsexpansion i Europa och sedan USA under 2022-2023, samt den förestående börsnoteringen på Nasdaq First North Growth Market under hösten.
“Gradientech is going for a distribution market launch, so we have set our launch countries in Europe. It will be launched in Spain, Portugal, the UK, Sweden, and the Nordics as the first launch countries. So, we are working with the leading clinical microbiology distributors in these areas […] We are expecting of course to prove the market traction of the QuickMIC system in these countries and then grow in Europe. And also, the US expects clinical proofs from the European market”, säger Sara Thorslund i presentationen.
Se hela presentationen nedan: